Skip to main content
ScholarsBetaWeill Cornell Medicine

Publications

5 publications

Clinical research

3 studies

Active

2 studies
  • PI
    A Follow-Up, Open-Label, Research Evaluation of Sustained Treatment With Aficamten (CK-3773274) in Hypertrophic Cardiomyopathy (HCM)
    PHASE2; PHASE3 · Cytokinetics, Inc. · OPEN TO ACCRUAL (as of 2025)
    Symptomatic Hypertrophic Cardiomyopathy (HCM)
    NCT04848506
  • PI
    Hypertrophic Cardiomyopathy Clinical Research Database
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
Completed & closed trials (1)
  • PI
    A Phase 3, Multi-Center, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
    PHASE3 · Cytokinetics, Inc. · IRB STUDY CLOSURE (as of 2026)
    Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
    NCT06081894